… RV1 Rotarix®. RV5 RotaTeq®. S. pneumoniae … In 2006, RotaTeq® (RV5) was licensed as a pentavalent, oral, live three-dose vaccine series, and in 2008, Rotarix® (RV1) was licensed as a monovalent, oral, live two-dose vaccine series against rotavirus [13, 119] …
CITATION STYLE
Diez, H. L., Hayward, A., & VanDerKolk, K. (2017). Vaccine-Preventable Diseases and the Vaccines That Prevent Them. In Vaccine Science and Immunization Guideline (pp. 101–168). Springer International Publishing. https://doi.org/10.1007/978-3-319-60471-8_4
Mendeley helps you to discover research relevant for your work.